Home Cart Sign in  
Chemical Structure| 470-17-7 Chemical Structure| 470-17-7

Structure of Isoalantolactone
CAS No.: 470-17-7

Chemical Structure| 470-17-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Isoalantolactone is a naturally occuring sesquiterpene lactone isolated from Inula helenium with a role as an apoptosis inducer, an antifungal agent and a plant metabolite.

Synonyms: (+)-Isoalantolactone; Isohelenin; NSC 601353

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Isoalantolactone

CAS No. :470-17-7
Formula : C15H20O2
M.W : 232.32
SMILES Code : O=C(O[C@@](C[C@@]1(C)CCC2)([H])[C@]3([H])C[C@@]1([H])C2=C)C3=C
Synonyms :
(+)-Isoalantolactone; Isohelenin; NSC 601353
MDL No. :MFCD08689940
InChI Key :CVUANYCQTOGILD-QVHKTLOISA-N
Pubchem ID :73285

Safety of Isoalantolactone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SKOV-3 cells 10-50 μM 24 h IL inhibited SKOV-3 cell proliferation and induced G2/M phase cell cycle arrest PMC10157634
HEK293 cells 10 μM 6 h Inhibited K63-linked polyubiquitination of TRAF6 PMC6318348
OVCAR-3 cells 10-50 μM 24 h IL inhibited OVCAR-3 cell proliferation and induced G2/M phase cell cycle arrest PMC10157634
DU145 cells 2.5, 5, 10, 20, 30, 40, 50 and 60 μM 24 h IATL dose-dependently inhibited the growth of DU145 cells and induced apoptosis. PMC6292114
PC-3 cells 2.5, 5, 10, 20, 30, 40, 50 and 60 μM 24 h IATL dose-dependently inhibited the growth of PC-3 cells and induced apoptosis. PMC6292114
COS-7 cells 20 and 40 µM 24 h To evaluate the toxicity of Isoalantolactone on normal COS-7 cells. Results showed that Isoalantolactone had significantly lower toxicity on COS-7 cells compared to PANC-1 cells. PMC3334669
HPAC cells 20 and 40 µM 24 h To evaluate the effect of Isoalantolactone on growth inhibition in HPAC cells. Results showed that Isoalantolactone inhibited HPAC cell growth in a dose-dependent manner. PMC3334669
BxPC3 cells 20 and 40 µM 24 h To evaluate the effect of Isoalantolactone on growth inhibition in BxPC3 cells. Results showed that Isoalantolactone inhibited BxPC3 cell growth in a dose-dependent manner. PMC3334669
PANC-1 cells 20 and 40 µM 24 h To evaluate the effect of Isoalantolactone on growth inhibition and apoptosis in PANC-1 cells. Results showed that Isoalantolactone inhibited PANC-1 cell growth and induced apoptosis in a dose-dependent manner. PMC3334669
mouse bone marrow-derived macrophages (BMDMs) 2.5, 5, 10, 20 μM 12 h Inhibited LPS-induced NO production and iNOS expression PMC6318348
BV2 cells 1 μM and 2 μM 12 h IAL inhibited LPS-induced release of pro-inflammatory mediators in BV2 cells by activating the AKT/Nrf2/HO-1 pathway and inhibiting the NF-κB pathway PMC9497122
SN4741 cells 2 μM 24 h IAL regulated apoptosis-related proteins by activating the AKT/Nrf2 pathway, thereby suppressing the apoptosis of SN4741 cells induced by MPP+ PMC9497122
PC-3 cells 15 μM 24 h IATL and cisplatin combination significantly suppressed PC-3 cell growth and induced apoptosis. PMC8093765
DU145 cells 15 μM 24 h IATL and cisplatin combination significantly suppressed DU145 cell growth and induced apoptosis. PMC8093765
HEK293T cells 100 μM 30 min To detect the direct interaction between Isoalantolactone and survivin protein by CETSA, the results showed that Isoalantolactone might induce thermal stability changes of survivin protein by direct binding. PMC10281474
K562R cells 2.5, 5, 10, 20, 40, 80 μM 0, 12, 24, 36, 48 h To evaluate the anti-proliferative effect of Isoalantolactone on K562R cells, the results showed that Isoalantolactone inhibited the proliferation of K562R cells in a dose- and time-dependent manner, with an IC50 value of 19.32 μM at 48 h. PMC10281474
K562 cells 2.5, 5, 10, 20, 40, 80 μM 0, 12, 24, 36, 48 h To evaluate the anti-proliferative effect of Isoalantolactone on K562 cells, the results showed that Isoalantolactone inhibited the proliferation of K562 cells in a dose- and time-dependent manner, with an IC50 value of 5.04 μM at 48 h. PMC10281474
KBM5T315I cells 2.5, 5, 10, 20, 40, 80 μM 0, 12, 24, 36, 48 h To evaluate the anti-proliferative effect of Isoalantolactone on KBM5T315I cells, the results showed that Isoalantolactone inhibited the proliferation of KBM5T315I cells in a dose- and time-dependent manner, with an IC50 value of 15.13 μM at 48 h. PMC10281474
KBM5 cells 2.5, 5, 10, 20, 40, 80 μM 0, 12, 24, 36, 48 h To evaluate the anti-proliferative effect of Isoalantolactone on KBM5 cells, the results showed that Isoalantolactone inhibited the proliferation of KBM5 cells in a dose- and time-dependent manner, with an IC50 value of 8.58 μM at 48 h. PMC10281474

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice (nu/nu) DU145 xenograft model Intraperitoneal injection 10 mg/kg Once every other day for 49 days IATL significantly inhibited the growth of DU145 xenograft tumors without exhibiting toxicity. PMC6292114
CD1 mice Acute and chronic toxicity model Intraperitoneal injection 100 mg/kg Once daily for 7 or 30 days To evaluate the acute and chronic toxicity of Isoalantolactone in CD1 mice. Results showed that Isoalantolactone did not induce any acute or chronic toxicity at a dose of 100 mg/kg body weight. PMC3334669
C57/BL6 mice LPS-induced acute lung injury (ALI) model Intraperitoneal injection 20 mg/kg Once Alleviated pulmonary pathological changes, neutrophil infiltration, and pro-inflammatory cytokine expression PMC6318348
C57/BL6 mice MPTP-induced Parkinson's disease model Gavage 10 mg/kg 17 days IAL ameliorated MPTP-induced PD-related pathological impairment and decreased motor activity in mice PMC9497122
Nude mice DU145 xenograft model Intraperitoneal injection 5 mg/kg Once every 3 days, continuous treatment IATL and cisplatin combination significantly inhibited tumor growth and weight. PMC8093765
C57BL/6 mice Chronic social defeat stress (CSDS) model Oral gavage 10 mg/kg Once daily for 5 days To evaluate the effects of LAT on CSDS-induced depression-like behaviors in mice. Results showed that LAT significantly improved depression-like behaviors, restored prefrontal cortex protein expression, reduced inflammatory cytokines IL-6 and TNF-α levels, and modulated gut microbiota. PMC10349788

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.30mL

0.86mL

0.43mL

21.52mL

4.30mL

2.15mL

43.04mL

8.61mL

4.30mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories